The Executive Committee of the World Anti-Doping Agency (WADA) approved the list of prohibited substances for 2023 to be published on the 1st and agreed to delay the inclusion of tramadol in it until January 1, 2024.
The AMA explained that this delay is to provide an additional year to communicate and educate the athletes, their entourage and medical staff to have a better understanding of the practical application of the painkiller in-competition ban.
The agency recalled that tramadol was in its monitoring program, which showed its significant use in sports, and that WADA-funded research also had have confirmed the potential of tramadol to improve physical performance.
The AMA’s decision follows the case of Colombian cyclist Nairo Quintana, who was disqualified from the last Tour de France after testing positive for tramadol by the International Cycling Union (UCI), whose regulations have banned its use in competition since March 1 , 2019 , despite not being on the AMA list.
The cyclist appealed his disqualification to the Court of Arbitration for Sport (CAS).
Source: La Verdad
I’m an experienced news author and editor based in New York City. I specialize in covering healthcare news stories for Today Times Live, helping to keep readers informed on the latest developments related to the industry. I have a deep understanding of medical topics, including emerging treatments and drugs, the changing laws that regulate healthcare providers, and other matters that affect public health.